Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
SGX:H02
Price:
9.64 SGD
-2.13%
Market Closed
Updated:
May 4, 2024
Haw Par Corporation Ltd
Cash from Financing Activities
|
Haw Par Corporation Ltd
Cash from Financing Activities Peer Comparison
Comparables:
WVE
H
1J5
I
42C
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Haw Par Corporation Ltd
SGX:H02
|
Cash from Financing Activities
-S$79.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-8%
|
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Cash from Financing Activities
$132.5m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Cash from Financing Activities
-S$17.3m
|
CAGR 3-Years
-114%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
I
|
IX Biopharma Ltd
SGX:42C
|
Cash from Financing Activities
S$736k
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Cash from Financing Activities?
Cash from Financing Activities
-79.3m
SGD
-79.3m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Cash from Financing Activities amounts to -79.3m SGD.
What is Haw Par Corporation Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-8%
-8%
Over the last year, the Cash from Financing Activities growth was -108%. The average annual Cash from Financing Activities growth rates for Haw Par Corporation Ltd have been -2% over the past three years , -2% over the past five years , and -8% over the past ten years .
You don't have any saved screeners yet
